These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6390854)

  • 21. Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index.
    Douzdjian V; Rice JC; Gugliuzza KK; Fisch JC; Carson RW
    Clin Transplant; 1996 Jun; 10(3):310-5. PubMed ID: 8826672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 23. Nursing review of the use and administration of antilymphocyte globulin in renal transplantation.
    Downs SA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):49-51. PubMed ID: 7009705
    [No Abstract]   [Full Text] [Related]  

  • 24. Steroid-resistant rejection: the effect of ATG on renal allograft survival.
    Jakobsen A; Albrechtsen D; Leivestad T; Sødal G; Talseth T; Flatmark A
    Transplant Proc; 1990 Feb; 22(1):225. PubMed ID: 2309320
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretransplant assays of alloimmunity in predicting renal graft outcome.
    Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
    Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of azathioprine on kidney allograft tolerance induced by rabbit ATG and donor bone marrow in primates.
    Thomas J; Carver M; Cunningham P; Gonder J; McGaley C; Sash C; Thomas F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):472-5. PubMed ID: 3547827
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac allograft survival in rhesus primates treated with total lymphoid irradiation and rabbit antithymocyte globulin.
    Bieber CP; Jamieson SW; Raney A; Burton NA; Bogarty S; Hoppe R; Kaplan HS; Strober S; Stinson EB
    Surg Forum; 1979; 30():284-6. PubMed ID: 120018
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations.
    MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J
    Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 36. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract]   [Full Text] [Related]  

  • 37. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract]   [Full Text] [Related]  

  • 39. Graft mucormycosis in a renal allograft recipient.
    Ahmad M
    J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of antithymocyte globulin (dose by rosette protocol) in pediatric renal allograft recipients.
    Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
    Transplantation; 1979 Oct; 28(4):291-3. PubMed ID: 388761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.